Effectiveness of Electrical Neurostimulation in Cyclic Vomiting Syndrome.
NCT: NCT04721171 · TERMINATED
Brief Summary
We hypothesize that 1) Neurostimulation via a novel auricular percutaneous electrical nerve field stimulation (PENFS) device is a safe, non-invasive opioid-sparing alternative therapy for severe abdominal pain, nausea, and vomiting associated with CVS and will reduce the need for opioids. We also hypothesize that 2) PENFS reduces the length of stay (LOS), and improves patient satisfaction. We propose the following specific aim: Aim 1. Investigate the efficacy of PENFS compared to a sham in patients with CVS seen in the ED or in the clinic or hospitalized with an acute CVS episode. Objectives: 1. Demonstrate reduction in abdominal pain, nausea, and vomiting using validated tools. 2. Obviate or reduce the need for opioids. 3. Reduce the length of hospital stay and improve patient satisfaction. This approach will specifically address the current opioid problem using a novel, non-invasive neurostimulation therapy with proven efficacy for opioid withdrawal. Long-term, it may improve health care outcomes and significantly reduce overall health care costs.
Frequently Asked Questions
What is Effectiveness of Electrical Neurostimulation in Cyclic Vomiting Syndrome.?
Effectiveness of Electrical Neurostimulation in Cyclic Vomiting Syndrome. is a clinical trial registered under NCT04721171. Current status: TERMINATED.
What is the status of NCT04721171?
The current status of NCT04721171 (Effectiveness of Electrical Neurostimulation in Cyclic Vomiting Syndrome.) is: TERMINATED.
When did Effectiveness of Electrical Neurostimulation in Cyclic Vomiting Syndrome. start?
Effectiveness of Electrical Neurostimulation in Cyclic Vomiting Syndrome. started on 2019-04-23.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.